On November 20, 2023, the World Health Organization’s (WHO) 2023 (Third Edition) Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological, and substance use disorders introduced revised guidelines. The mhGAP guideline supports countries to…
On November 13, 2023, the U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), released a report titled “Key Substance Use and Mental Health Indicators in…
Pam shares her story of benzodiazepine harm and healing for our #BenzoStories series. #BenzoStories is a series by our nonprofit, Benzodiazepine Information Coalition, sharing powerful stories of patient harm associated with prescribed benzodiazepines. To stay…
Watch this compelling testimony on Massachusetts Bills H.2000 and S.1236, two crucial pieces of legislation aimed at requiring informed consent at the point of prescription within the state of Massachusetts. These bills are collectively titled…
Michael shares his story of benzodiazepine harm and healing for our #BenzoStories series. #BenzoStories is a series by our nonprofit, Benzodiazepine Information Coalition, sharing powerful stories of patient harm associated with prescribed benzodiazepines. To stay…
We are searching for patients who experienced abrupt benzodiazepine discontinuation connected to the state of Illinois. Those abruptly discontinued from benzodiazepine medication may face significant losses that justify legal action. These losses may be quite…
James shares his story of benzodiazepine harm and healing for our #BenzoStories series. #BenzoStories is a series by our nonprofit, Benzodiazepine Information Coalition, sharing powerful stories of patient harm associated with prescribed benzodiazepines. To stay…
Make BIC’s Next Year Even More Impactful! Your Support and Tax-Deductible Gifts Are Vital! Although we dream of a future where BIC can close its doors because the medical field has wholeheartedly addressed benzodiazepine harm,…
